Dear valued partners and colleagues,
Welcome to ICARS’ spring newsletter. It is our pleasure to share this edition with you, and we hope you find it both informative and engaging.
In this issue, we are pleased to present the ICARS 2025 Year in review report, highlighting key achievements and milestones from the past year. You will also find updates on new and ongoing collaborations, insights from ICARS-supported projects, and a selection of newly published resources.
ICARS extends its sincere thanks for your continued support and partnership. Your engagement remains essential to advancing sustainable, context-specific solutions to antimicrobial resistance.
We invite you to follow us on LinkedIn for the latest ICARS news, recommended readings, and upcoming events. If you think this newsletter may be of interest to colleagues in your network, we encourage you to share it and invite them to subscribe.
With warm regards,
The ICARS Team

We are excited to share the ICARS 2025 Year in Review report, capturing a year defined by country-led solutions, strengthened partnerships, and measurable progress against antimicrobial resistance. The report includes an overview of the ICARS-supported project portfolio, key results from projects completed in 2025, case studies showcasing the ICARS model in action, as well as reflections from diverse partners engaged with ICARS.

ICARS is pleased to announce its new role as an implementation partner in the Team Europe Initiative for Africa. Through this partnership, ICARS will work alongside leading global and African institutions to strengthen Africa’s capacity to prevent, detect, and respond to AMR across human, animal, and environmental health sectors.

In February, the East, Central and Southern African Health Community (ECSA-HC) signed a Memorandum of Understanding with ICARS to collaborate to accelerate evidence-based solutions for AMR. The signing took place at the closing of the AMR Pre-Conference Meeting in Eswatini.

In January, delegates from Bangladesh and Denmark visited ICARS to discuss ICARS-supported projects in Bangladesh and the opportunities for future engagement in the country’s AMR space.

C-CAMP, with support from ICARS, has announced seven awarded applicants for the inaugural edition of the C-CAMP One Health AMR Challenge 2025. The challenge was launched in July 2025 and received about 100 high-quality applications from innovators and startup companies across India.

An independent evaluation by the EUCAST Development Laboratory supported by ICARS found that the free Antibiogo app is a highly accurate, easy-to-use tool with strong potential to help non-expert laboratory staff produce reliable antimicrobial susceptibility testing results in resource-limited settings.




